- Low
- 58,338
- Average
- 66,561
- Median
- 66,920
- High
- 77,860
Geron Salary
55
60
24
Geron average salary is $66,561, median salary is $66,920 with a salary range from $58,338 to $77,860.
Geron salaries are collected from government agencies and companies. Each salary is associated with a real job position. Geron salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Geron salaries are collected from government agencies and companies. Each salary is associated with a real job position. Geron salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
| Job Title | Salaries | City | Year | More info |
Related Geron Salary
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Geron salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
Geron Jobs
| See more Geron Jobs» | |
| Search All Jobs | |
Patents information
1887
All Patents
457
Grant Patents
1148
Patents Pending
443
Patents Families
More Recent
Geron... Information
- Geron Corporation
- Industry: BioTech/Drugs
- City: Menlo Park, CA
- Geron Corporation is a development stage biopharmaceutical company focused on developing and commercializing therapeutic and diagnostic products for applications in oncology and regenerative medicine, and research tools for drug discovery. The Company's product development programs are based upon three patented core technologies: telomerase, human embryonic stem cells and nuclear transfer. The Company is working to develop anti-cancer therapies based on telomerase inhibitors, oncolytic (cancer-killing) viruses and telomerase vaccines. The Company also intends to continue to develop and commercialize products using telomerase as a marker for cancer diagnosis, prognosis, patient monitoring and screening.
